 Adrenergic beta-Antagonists
"Adrenergic beta-Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
| Descriptor ID |
D000319
|
| MeSH Number(s) |
D27.505.519.625.050.200.200 D27.505.696.577.050.200.200
|
| Concept/Terms |
Adrenergic beta-Antagonists- Adrenergic beta-Antagonists
- Adrenergic beta Antagonists
- beta-Antagonists, Adrenergic
- beta-Adrenergic Receptor Blockaders
- Blockaders, beta-Adrenergic Receptor
- Receptor Blockaders, beta-Adrenergic
- beta Adrenergic Receptor Blockaders
- beta-Adrenergic Blockers
- Blockers, beta-Adrenergic
- beta Adrenergic Blockers
- beta-Blockers, Adrenergic
- Adrenergic beta-Blockers
- beta Blockers, Adrenergic
- Adrenergic beta-Receptor Blockaders
- Adrenergic beta Receptor Blockaders
- Blockaders, Adrenergic beta-Receptor
- beta-Receptor Blockaders, Adrenergic
- beta-Adrenergic Blocking Agents
- Agents, beta-Adrenergic Blocking
- Blocking Agents, beta-Adrenergic
- beta Adrenergic Blocking Agents
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-Antagonists".
This graph shows the total number of publications written about "Adrenergic beta-Antagonists" by people in this website by year, and whether "Adrenergic beta-Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 4 | 0 | 4 | | 1991 | 1 | 0 | 1 | | 1992 | 3 | 2 | 5 | | 1993 | 3 | 0 | 3 | | 1994 | 5 | 0 | 5 | | 1995 | 2 | 0 | 2 | | 1996 | 8 | 4 | 12 | | 1997 | 5 | 0 | 5 | | 1998 | 6 | 3 | 9 | | 1999 | 4 | 2 | 6 | | 2000 | 7 | 0 | 7 | | 2001 | 9 | 8 | 17 | | 2002 | 3 | 1 | 4 | | 2003 | 5 | 3 | 8 | | 2004 | 7 | 2 | 9 | | 2005 | 3 | 7 | 10 | | 2006 | 4 | 6 | 10 | | 2007 | 7 | 2 | 9 | | 2008 | 9 | 2 | 11 | | 2009 | 5 | 1 | 6 | | 2010 | 8 | 4 | 12 | | 2011 | 7 | 5 | 12 | | 2012 | 8 | 4 | 12 | | 2013 | 11 | 2 | 13 | | 2014 | 4 | 4 | 8 | | 2015 | 4 | 3 | 7 | | 2016 | 3 | 1 | 4 | | 2017 | 4 | 5 | 9 | | 2018 | 2 | 5 | 7 | | 2019 | 1 | 6 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic beta-Antagonists" by people in Profiles.
-
Ward R, Huang Z, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Katona BG, Mahaffey KW, Norgren L, Vemulapalli S, Povsic TJ, Mehta R, Hiatt WR, Patel MR, Jones WS. Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial. Am Heart J. 2020 02; 220:51-58.
-
Xie JX, Gunzburger EC, Kaun L, Plomondon ME, Barón AE, Waldo SW, Virani SS, Maddox TM, Mavromatis K. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005455.
-
Cuneo BF, Kaizer AM, Clur SA, Swan H, Herberg U, Winbo A, Rydberg A, Haugaa K, Etheridge S, Ackerman MJ, Dagradi F, Killen SAS, Wacker-Gussmann A, Benson DW, Wilde AAM, Pan Z, Lam A, Spazzolini C, Horigome H, Schwartz PJ. Mothers with long QT syndrome are at increased risk for fetal death: findings from a multicenter international study. Am J Obstet Gynecol. 2020 03; 222(3):263.e1-263.e11.
-
Page RL, Allen LA. Cocaine, Heart Failure, and Carvedilol: Triangulating the Safety of ß-Blocker Therapy. JACC Heart Fail. 2019 09; 7(9):779-781.
-
Cardet JC, Jiang X, Lu Q, Gerard N, McIntire K, Boushey HA, Castro M, Chinchilli VM, Codispoti CD, Dyer AM, Holguin F, Kraft M, Lazarus S, Lemanske RF, Lugogo N, Mauger D, Moore WC, Moy J, Ortega VE, Peters SP, Smith LJ, Solway J, Sorkness CA, Sumino K, Wechsler ME, Wenzel S, Israel E. Reply. J Allergy Clin Immunol. 2019 09; 144(3):873-874.
-
Adamek KE, Ramadurai D, Gunzburger E, Plomondon ME, Ho PM, Raghavan S. Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction. J Am Heart Assoc. 2019 02 05; 8(3):e011448.
-
Kahook MY, Serle JB, Mah FS, Kim T, Raizman MB, Heah T, Ramirez-Davis N, Kopczynski CC, Usner DW, Novack GD. Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2). Am J Ophthalmol. 2019 04; 200:130-137.
-
Gelfand EW, Kaplan AG, Hayden ML, Bender BG. Ever-evolving Concepts in the Asthma Management Landscape in the United States. J Fam Pract. 2018 10; 67(10 Suppl):S4-S11.
-
Gelfand EW, Wechsler ME. Confronting the Challenges of Severe Asthma. J Fam Pract. 2018 10; 67(10 Suppl):S19-S26.
-
Arnold SV, Yap J, Lam CSP, Tang F, Tay WT, Teng THK, McGuire DK, Januzzi JL, Fonarow GC, Masoudi FA, Kosiborod M. Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison. Diabetes Obes Metab. 2019 02; 21(2):261-266.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|